Clinical Trial Update: Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for ACTiMuS bone marrow-derived cellular therapy in progressive multiple sclerosis. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• ACTiMuS Bone Marrow-derived Cellular Therapy

Snippet

Sponsor: North Bristol NHS Trust | Conditions: Progressive Multiple Sclerosis | Phase 2 | Status: UNKNOWN